Research results on the effects of BioBran and clinical data were presented at the Society of Surgical Oncology in Indonesia.

Research results on the effects of BioBran and clinical data were presented at the Society of Surgical Oncology in Indonesia.

BioBran was presented at the Round Table Discussion with oncologists and PERABOI (Indonesian Society of Surgical Oncology) held under the sponsorship of the Indonesian Agency of Daiwa Pharmaceutical Co., Ltd.

At the Round Table Discussion held in Jakarta, Indonesia on October 29, 2008, an American medical doctor, Dr. Ali explained about cancer and immunity (immunosenescence and immune reconstitution) with a presentation titled “Immunomodulation & Carcinogenesis” to a group of hematological oncologists. Moreover, he introduced the mechanism and clinical data for BioBran with a presentation titled “BioBran reversing to eliminate cancer”.

Oncological surgeons mainly gathered at the PERABOI held in Solo, Indonesia from October 30 to November 1 and another presentation by Dr. Ali was also held there.

In the presentation on BioBran at this cancer symposium, there were high expectations and interest prior to its start, and there were successive questions regarding the amount and duration of intake and mechanism of action after the presentation on that day.

Exhibition space was established in parallel with the conference room at the PERABOI, and companies sponsored various exhibition booths. A number of participants visited the booth introducing BioBran, which infers that cancer and immunity are also important issues in Indonesia. As for Daiwa Pharmaceutical, in order to respond to such expectations, in addition to accumulating clinical data, we will bring the large possibility for the future market in the whole of Asia into view and focus on business.

BioBran has already been marketed in 46 countries worldwide and has received high evaluations from medical professionals. It is increasing its steady sales growth and is expected to expand its window.

・